Digital Biomanufacturing market 2023 – Industry Growth by 2035
Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics and process optimization to transform the available information into actionable insights.
In the near future, this industry is anticipated to witness more investment and collaborations, while greater skillset among employees and adequate knowledge on operation will result in widespread adoption in the long run. Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls; majority of these platforms support manufacturing of proteins and antibodies.
The financial opportunity associated with the digital manufacturing market has been analyzed across the following segments:
Type of Technology
Process Analytical Technology (PAT)
Data Analysis Software (DAS)
Manufacturing Execution Systems (MES)
Digital Twins
Deployment Options
Cloud-based Deployment Options
On-premises Deployment Options
Type(s) of Biologic(s) Manufactured
Antibodies
Cell and Gene Therapies
Proteins
Vaccines
Others
Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North America
The Digital Biomanufacturing Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
AspenTech
Bioreactors.net
Dassault Systèmes
FUJIFILM Diosynth Biotechnologies
GE Healthcare
Körber
Merck
Sartorius
Thermo Fisher Scientific
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Technology Competitiveness Analysis
6. Company Profiles
7. Benchmarking Analysis
8. Partnerships and Collaborations
9. Market Concentration Analysis
10. Industry Lifecycle Analysis
11. Market Forecast and Opportunity Analysis
12. Concluding Remarks
13. Interview Transcripts
14. Appendix I: Tabulated Data
15. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
Learn from experts: do you know about these emerging industry trends?
Applications of Blockchain in Various Sectors: An Introduction
Intracellular Drug Delivery – Future Potential
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #ProcessAnalyticalTechnologymarket #digitalmanufacturingcompanies
Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics and process optimization to transform the available information into actionable insights.
In the near future, this industry is anticipated to witness more investment and collaborations, while greater skillset among employees and adequate knowledge on operation will result in widespread adoption in the long run. Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls; majority of these platforms support manufacturing of proteins and antibodies.
The financial opportunity associated with the digital manufacturing market has been analyzed across the following segments:
Type of Technology
Process Analytical Technology (PAT)
Data Analysis Software (DAS)
Manufacturing Execution Systems (MES)
Digital Twins
Deployment Options
Cloud-based Deployment Options
On-premises Deployment Options
Type(s) of Biologic(s) Manufactured
Antibodies
Cell and Gene Therapies
Proteins
Vaccines
Others
Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North America
The Digital Biomanufacturing Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
AspenTech
Bioreactors.net
Dassault Systèmes
FUJIFILM Diosynth Biotechnologies
GE Healthcare
Körber
Merck
Sartorius
Thermo Fisher Scientific
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Technology Competitiveness Analysis
6. Company Profiles
7. Benchmarking Analysis
8. Partnerships and Collaborations
9. Market Concentration Analysis
10. Industry Lifecycle Analysis
11. Market Forecast and Opportunity Analysis
12. Concluding Remarks
13. Interview Transcripts
14. Appendix I: Tabulated Data
15. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
Learn from experts: do you know about these emerging industry trends?
Applications of Blockchain in Various Sectors: An Introduction
Intracellular Drug Delivery – Future Potential
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #ProcessAnalyticalTechnologymarket #digitalmanufacturingcompanies
Digital Biomanufacturing market 2023 – Industry Growth by 2035
Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics and process optimization to transform the available information into actionable insights.
In the near future, this industry is anticipated to witness more investment and collaborations, while greater skillset among employees and adequate knowledge on operation will result in widespread adoption in the long run. Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls; majority of these platforms support manufacturing of proteins and antibodies.
The financial opportunity associated with the digital manufacturing market has been analyzed across the following segments:
Type of Technology
Process Analytical Technology (PAT)
Data Analysis Software (DAS)
Manufacturing Execution Systems (MES)
Digital Twins
Deployment Options
Cloud-based Deployment Options
On-premises Deployment Options
Type(s) of Biologic(s) Manufactured
Antibodies
Cell and Gene Therapies
Proteins
Vaccines
Others
Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North America
The Digital Biomanufacturing Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
AspenTech
Bioreactors.net
Dassault Systèmes
FUJIFILM Diosynth Biotechnologies
GE Healthcare
Körber
Merck
Sartorius
Thermo Fisher Scientific
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Technology Competitiveness Analysis
6. Company Profiles
7. Benchmarking Analysis
8. Partnerships and Collaborations
9. Market Concentration Analysis
10. Industry Lifecycle Analysis
11. Market Forecast and Opportunity Analysis
12. Concluding Remarks
13. Interview Transcripts
14. Appendix I: Tabulated Data
15. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
Learn from experts: do you know about these emerging industry trends?
Applications of Blockchain in Various Sectors: An Introduction
Intracellular Drug Delivery – Future Potential
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #ProcessAnalyticalTechnologymarket #digitalmanufacturingcompanies
0 Comments
0 Shares